These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A role for leukotrienes in cyclosporine nephrotoxicity. Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628 [TBL] [Abstract][Full Text] [Related]
4. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Ruetten H; Thiemermann C; Vane JR Br J Pharmacol; 1996 May; 118(1):198-204. PubMed ID: 8733596 [TBL] [Abstract][Full Text] [Related]
6. The management of cyclosporine-induced nephrotoxicity after cardiac transplantation. Parameshwar J; Large SR Transplantation; 2000 Apr; 69(8):1544-5. PubMed ID: 10836357 [No Abstract] [Full Text] [Related]
7. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats. Bunting MW; Widdop RE Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129 [TBL] [Abstract][Full Text] [Related]
8. Chronic cyclosporine nephrotoxicity: new insights and preventive strategies. Li C; Lim SW; Sun BK; Yang CW Yonsei Med J; 2004 Dec; 45(6):1004-16. PubMed ID: 15627291 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Andoh TF; Lindsley J; Franceschini N; Bennett WM Transplantation; 1996 Aug; 62(3):311-6. PubMed ID: 8779675 [TBL] [Abstract][Full Text] [Related]
10. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat. McCulloch KM; Docherty C; MacLean MR Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569 [TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats. Caires A; Fernandes GS; Leme AM; Castino B; Pessoa EA; Fernandes SM; Fonseca CD; Vattimo MF; Schor N; Borges FT Braz J Med Biol Res; 2017 Dec; 51(2):e6373. PubMed ID: 29267497 [TBL] [Abstract][Full Text] [Related]
12. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242. Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985 [TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670. Douglas SA; Edwards RM; Elliott JD; Ohlstein EH Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741 [TBL] [Abstract][Full Text] [Related]
14. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat. Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832 [TBL] [Abstract][Full Text] [Related]
15. Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs. Brooks DP; dePalma PD; Gellai M; Nambi P; Ohlstein EH; Elliott JD; Gleason JG; Ruffolo RR J Pharmacol Exp Ther; 1994 Nov; 271(2):769-75. PubMed ID: 7965795 [TBL] [Abstract][Full Text] [Related]
16. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists. Hay DW; Luttmann MA J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312 [TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254 [TBL] [Abstract][Full Text] [Related]
18. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade. El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674 [TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity. Shihab FS; Bennett WM; Yi H; Andoh TF Transplantation; 2001 Jul; 72(1):164-8. PubMed ID: 11468554 [TBL] [Abstract][Full Text] [Related]
20. Prevention of cyclosporine-induced nephrotoxicity by prazosin hydrochloride, an alpha-1-adrenoreceptor blocker. Ishikawa A; Suzuki K; Fujita K Transplant Proc; 1996 Jun; 28(3):1360-1. PubMed ID: 8658694 [No Abstract] [Full Text] [Related] [Next] [New Search]